DK45590D0 - - Google Patents
Info
- Publication number
- DK45590D0 DK45590D0 DK045590A DK45590A DK45590D0 DK 45590 D0 DK45590 D0 DK 45590D0 DK 045590 A DK045590 A DK 045590A DK 45590 A DK45590 A DK 45590A DK 45590 D0 DK45590 D0 DK 45590D0
- Authority
- DK
- Denmark
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK045590A DK45590D0 (US06174465-20010116-C00003.png) | 1990-02-21 | 1990-02-21 | |
NZ237176A NZ237176A (en) | 1990-02-21 | 1991-02-20 | Insulin cobalt iii complex compositions |
IE057991A IE910579A1 (en) | 1990-02-21 | 1991-02-20 | Novel protein compositions |
EP91904980A EP0516704B1 (en) | 1990-02-21 | 1991-02-21 | Novel insulin compositions |
HU922721Q HUT63858A (en) | 1990-02-21 | 1991-02-21 | Process for producing new insulin complexes |
PCT/DK1991/000052 WO1991012817A1 (en) | 1990-02-21 | 1991-02-21 | Novel insulin compositions |
JP3504590A JPH05503940A (ja) | 1990-02-21 | 1991-02-21 | 新規インスリン組成物 |
AT91904980T ATE97002T1 (de) | 1990-02-21 | 1991-02-21 | Neue zusammensetzungen auf insulinbasis. |
ZA911279A ZA911279B (en) | 1990-02-21 | 1991-02-21 | Novel protein compositions |
DE91904980T DE69100626D1 (de) | 1990-02-21 | 1991-02-21 | Neue zusammensetzungen auf insulinbasis. |
AU73378/91A AU641991B2 (en) | 1990-02-21 | 1991-02-21 | Novel insulin compositions |
PT96841A PT96841A (pt) | 1990-02-21 | 1991-02-21 | Processo para a preparacao de composicoes farmaceuticas de insulina contendo novos complexos insulinicos de co(iii) |
MX9203359A MX9203359A (es) | 1990-02-21 | 1991-02-21 | Nuevas composiciones farmaceuticas de insulina. |
CA002075982A CA2075982A1 (en) | 1990-02-21 | 1991-02-21 | Insulin compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK045590A DK45590D0 (US06174465-20010116-C00003.png) | 1990-02-21 | 1990-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK45590D0 true DK45590D0 (US06174465-20010116-C00003.png) | 1990-02-21 |
Family
ID=8093754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK045590A DK45590D0 (US06174465-20010116-C00003.png) | 1990-02-21 | 1990-02-21 |
Country Status (12)
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9316895D0 (en) * | 1993-08-13 | 1993-09-29 | Guy S And St Thomas Hospitals | Hepatoselective insulin analogues |
US6342225B1 (en) | 1993-08-13 | 2002-01-29 | Deutshces Wollforschungsinstitut | Pharmaceutical active conjugates |
US6011007A (en) * | 1993-09-17 | 2000-01-04 | Novo Nordisk A/S | Acylated insulin |
US6869930B1 (en) | 1993-09-17 | 2005-03-22 | Novo Nordisk A/S | Acylated insulin |
US6251856B1 (en) | 1995-03-17 | 2001-06-26 | Novo Nordisk A/S | Insulin derivatives |
US6451762B1 (en) | 1997-10-24 | 2002-09-17 | Novo Nordisk A/S | Aggregates of human insulin derivatives |
ES2472421T3 (es) | 2003-08-05 | 2014-07-01 | Novo Nordisk A/S | Nuevos derivados de insulina |
EP2264065B1 (en) | 2003-08-05 | 2017-03-08 | Novo Nordisk A/S | Novel insulin derivatives |
ES2438145T3 (es) | 2005-02-02 | 2014-01-16 | Novo Nordisk A/S | Nuevos derivados de insulina |
PT1969004E (pt) | 2005-12-28 | 2011-11-25 | Novo Nordisk As | Composições que compreendem uma insulina acilada e zinco e método para criar tais composições |
JP5550338B2 (ja) | 2006-07-31 | 2014-07-16 | ノボ・ノルデイスク・エー/エス | ペグ化持続型インスリン |
CN101541830A (zh) | 2006-09-22 | 2009-09-23 | 诺沃-诺迪斯克有限公司 | 蛋白酶抗性的胰岛素类似物 |
ES2563038T3 (es) | 2007-04-30 | 2016-03-10 | Novo Nordisk A/S | Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca |
ES2744384T3 (es) | 2007-06-13 | 2020-02-24 | Novo Nordisk As | Formulación farmacéutica que comprende un derivado de insulina |
ES2618073T3 (es) | 2008-03-14 | 2017-06-20 | Novo Nordisk A/S | Análogos de insulina estabilizados frente a proteasas |
EP2910571B1 (en) | 2008-03-18 | 2016-10-05 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
US9603904B2 (en) | 2008-10-30 | 2017-03-28 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections with less than daily injection frequency |
BR112013010345A2 (pt) | 2010-10-27 | 2017-07-25 | Novo Nordisk As | tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção |
CA2870313A1 (en) | 2012-04-11 | 2013-10-17 | Novo Nordisk A/S | Insulin formulations |
EP2991672A1 (en) | 2013-04-30 | 2016-03-09 | Novo Nordisk A/S | Novel administration regime |
WO2015052088A1 (en) | 2013-10-07 | 2015-04-16 | Novo Nordisk A/S | Novel derivative of an insulin analogue |
MX2019006463A (es) | 2016-12-16 | 2019-08-14 | Novo Nordisk As | Composiciones farmaceuticas que contienen insulina. |
US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE971500C (de) * | 1950-11-22 | 1959-02-05 | Organon Nv | Verfahren zur Herstellung von Insulin-Suspensionen mit verlaengerter Wirkung |
DE1107374B (de) * | 1958-01-31 | 1961-05-25 | Organon Nv | Verfahren zur Herstellung eines Insulin-Praeparates |
-
1990
- 1990-02-21 DK DK045590A patent/DK45590D0/da not_active Application Discontinuation
-
1991
- 1991-02-20 NZ NZ237176A patent/NZ237176A/en unknown
- 1991-02-20 IE IE057991A patent/IE910579A1/en unknown
- 1991-02-21 EP EP91904980A patent/EP0516704B1/en not_active Expired - Lifetime
- 1991-02-21 CA CA002075982A patent/CA2075982A1/en not_active Abandoned
- 1991-02-21 HU HU922721Q patent/HUT63858A/hu unknown
- 1991-02-21 AU AU73378/91A patent/AU641991B2/en not_active Expired - Fee Related
- 1991-02-21 WO PCT/DK1991/000052 patent/WO1991012817A1/en active IP Right Grant
- 1991-02-21 ZA ZA911279A patent/ZA911279B/xx unknown
- 1991-02-21 PT PT96841A patent/PT96841A/pt not_active Application Discontinuation
- 1991-02-21 JP JP3504590A patent/JPH05503940A/ja active Pending
- 1991-02-21 DE DE91904980T patent/DE69100626D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0516704A1 (en) | 1992-12-09 |
HU9202721D0 (en) | 1992-12-28 |
WO1991012817A1 (en) | 1991-09-05 |
ZA911279B (en) | 1991-10-30 |
CA2075982A1 (en) | 1991-08-22 |
PT96841A (pt) | 1991-11-29 |
DE69100626D1 (de) | 1993-12-16 |
NZ237176A (en) | 1991-12-23 |
JPH05503940A (ja) | 1993-06-24 |
AU641991B2 (en) | 1993-10-07 |
HUT63858A (en) | 1993-10-28 |
EP0516704B1 (en) | 1993-11-10 |
IE910579A1 (en) | 1991-08-28 |
AU7337891A (en) | 1991-09-18 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHS | Application shelved for other reasons than non-payment |